Alx Oncology Holdings (ALXO) Debt Ratio (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Debt Ratio data on file, last reported at 0.05 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 42.12% year-over-year to 0.05; the trailing twelve-month figure through Mar 2026 stood at 0.05 (down 42.12% YoY), and the FY2025 full-year result was 0.17, up 146.35% from the prior year.
• Debt Ratio slipped to 0.05 in Q1 2026, from 0.17 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.17 in Q4 2025 to a low of 0.01 in Q2 2022.
• A 5-year average of 0.06 and a median of 0.05 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 740.08% in 2022 and sank 42.12% in 2026, its largest moves.
• Tracing ALXO's Debt Ratio over 5 years: stood at 0.04 in 2022, then gained by 10.33% to 0.04 in 2023, then jumped by 68.65% to 0.07 in 2024, then soared by 146.35% to 0.17 in 2025, then sank by 71.09% to 0.05 in 2026.
• Business Quant data shows ALXO's Debt Ratio at 0.05 in Q1 2026, 0.17 in Q4 2025, and 0.12 in Q3 2025.